Mustang Bio

MBIO

Mustang Bio (NASDAQ: MBIO) is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, so …

Insider trades and stock quote 2022-2025

All insider trades at Mustang Bio

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
9/13/2022 BuyRosenwald, Lindsay Md Director $0.5 $2,582
9/13/2022 BuyLitchman, Manuel Md Director $0.5 $2,582
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)